medicationOTC supplementAvailable both as an OTC and prescription-strength proton pump inhibitor in the US
OmeprazoleBenefits, Dosage & Interactions
Also known as: prilosec
Omeprazole is a medication classified as a proton pump inhibitor (PPI). It is widely used to reduce the amount of acid produced in the stomach. It is typically taken in the morning. Omeprazole is a controlled substance in some jurisdictions.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Plasma half-life
Roughly 0.5-1 hour, though acid suppression outlasts plasma levels
Typical timing
morning
Food rule
empty stomach
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The cited randomized trial compared omeprazole 20 mg once daily against esomeprazole 20 mg and 40 mg once daily for erosive esophagitis healing[1]
- Route studied
- Oral[1]
- Frequency
- Once daily in the cited trial[1]
- Cycle length
- 4 and 8 week healing endpoints were assessed in the cited trial[1]
- Half-life
- Roughly 0.5-1 hour, though acid suppression outlasts plasma levels[1]
- Storage
- Room temperature, sealed, protected from moisture[1]
Reported for Omeprazole in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Omeprazole entry is written from. Each number matches an inline marker above.
- [1]Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trialKahrilas PJ, Falk GW, Johnson DA, et al. · The American Journal of Gastroenterology · 2001 · Peer-reviewed · PMID 11280530
How to track Omeprazole doses
Tracking Omeprazole well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Omeprazole with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is morning. Take it on an empty stomach, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Omeprazole through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Omeprazole alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg
- Time of day and whether it was taken on an empty stomach
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Omeprazole dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Omeprazole?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Omeprazole is a medication classified as a proton pump inhibitor (PPI). It is widely used to reduce the amount of acid produced in the stomach. Conditions treated with omeprazole include gastroesophageal reflux disease (GERD), stomach ulcers, and Zollinger-Ellison syndrome. It can also be used to treat erosion of the esophagus caused by stomach acid. Omeprazole is available as both an over-the-counter and prescription medication, typically in capsule or tablet form. Originally approved by the FDA in 1989, it is listed on the World Health Organization's List of Essential Medicines (DrugBank, FDA label).
What does the research say about Omeprazole?
Tap a section to expand.
Omeprazole works by irreversibly blocking the action of proton pumps in the stomach's parietal cells. These proton pumps, specifically the H+/K+-ATPase enzyme system, are responsible for the final step in stomach acid secretion. By inhibiting these pumps, omeprazole significantly reduces the production of gastric acid. This process is time-dependent, meaning it takes several days of consistent use to achieve the maximal acid suppression effect. The inhibition is sustained as new proton pumps are synthesized, hence the need for daily dosing. Once absorbed, omeprazole is transported to the acidic secretory canaliculi of the parietal cells where it is converted into its active form. This active sulfenamide form then binds to the cysteine residues of the H+/K+-ATPase, leading to its inactivation (DrugBank, PubChem).
Source for this section: Sources for How does Omeprazole work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefit of omeprazole is the reduction of stomach acid, which provides therapeutic relief for a range of acid-related conditions:
* **Gastroesophageal Reflux Disease (GERD):** Omeprazole is effective in treating the symptoms of GERD, such as heartburn and acid regurgitation, and promotes the healing of esophageal damage (esophagitis) caused by stomach acid (MedlinePlus, NIH ODS).
* **Peptic Ulcers:** It helps to heal stomach (gastric) and duodenal ulcers by reducing acid production, allowing the damaged lining to recover. It is also used in combination with antibiotics to eradicate *Helicobacter pylori* infection, a common cause of ulcers (Mayo Clinic, DrugBank).
* **Zollinger-Ellison Syndrome:** This rare condition involves the overproduction of stomach acid due to a tumor. Omeprazole is crucial in managing the extreme acid secretion and associated symptoms in patients with Zollinger-Ellison syndrome (NIH ODS).
* **Erosive Esophagitis:** Omeprazole promotes the healing of erosion and inflammation in the esophagus caused by chronic acid reflux (FDA label).
* **Prevention of NSAID-induced Ulcers:** For individuals at high risk, omeprazole can be prescribed to prevent stomach ulcers caused by the long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) (Mayo Clinic).
Numerous clinical trials and systematic reviews support the efficacy of omeprazole in treating acid-related disorders. A Cochrane review highlighted its effectiveness in healing peptic ulcers and preventing recurrence, particularly in combination with antibiotics for *H. pylori*. The NIH Office of Dietary Supplements (ODS) and MedlinePlus cite extensive evidence for its use in GERD and erosive esophagitis, demonstrating significant symptom improvement and healing rates. Studies consistently show that omeprazole provides sustained acid suppression, which is critical for the healing of these conditions. The FDA approval for various indications is based on robust clinical data demonstrating its safety and effectiveness across diverse patient populations. Long-term studies have also evaluated its role in managing chronic acid production, especially in conditions like Zollinger-Ellison syndrome (Cochrane, NIH ODS, MedlinePlus, FDA label).
Common side effects of omeprazole are generally mild and may include headache, nausea, diarrhea, abdominal pain, vomiting, and flatulence. Less common but reported side effects include dry mouth, dizziness, rash, and fatigue. Most side effects are temporary and often resolve as the body adjusts to the medication. However, prolonged use of omeprazole has been associated with more serious adverse effects, including an increased risk of bone fractures (especially with high doses and long-term use), *Clostridium difficile* infection, and hypomagnesemia (low magnesium levels). Other reported long-term effects include kidney problems (interstitial nephritis), and vitamin B12 deficiency. Patients should report any unusual or severe symptoms to their healthcare provider. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Omeprazole should be used with caution in certain populations. Patients with liver disease may require dosage adjustments due to altered metabolism of the drug. Long-term use (typically over a year) has been linked to an increased risk of bone fractures of the hip, wrist, or spine, particularly in older individuals and those on high doses (FDA label). There is also an increased risk of *Clostridium difficile*-associated diarrhea (CDAD) with PPI use, which can range from mild diarrhea to severe colitis. Hypomagnesemia (low blood magnesium levels) can occur with prolonged use (usually three months or more) and may require magnesium supplementation or discontinuation of the drug. Patients experiencing persistent or worsening symptoms despite treatment should be re-evaluated to rule out underlying serious conditions, as omeprazole can mask symptoms of serious esophageal and gastric problems. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Omeprazole is contraindicated in individuals with known hypersensitivity to omeprazole, substituted benzimidazoles, or any component of the formulation. It should not be used in patients who are allergic to other proton pump inhibitors. Co-administration with rilpivirine-containing products, which are used to treat HIV-1 infection, is contraindicated due to potential for significant drug interactions through effects on gastric pH. Caution is advised for patients with severe hepatic impairment. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Omeprazole can interact with several medications, potentially altering their effectiveness or increasing the risk of side effects. Key interactions include:
* **Rilpivirine:** Co-administration is contraindicated as omeprazole significantly reduces the absorption and efficacy of rilpivirine, an antiretroviral drug.
* **Warfarin:** Omeprazole can increase the international normalized ratio (INR) for warfarin, requiring close monitoring and potential dose adjustments.
* **Clopidogrel:** Omeprazole may reduce the antiplatelet effect of clopidogrel by inhibiting the enzyme CYP2C19, which is needed to convert clopidogrel to its active form. This interaction could potentially increase the risk of cardiovascular events.
* **Methotrexate:** Concomitant use with high-dose methotrexate may delay its elimination, leading to increased methotrexate levels and potential toxicity.
* **Tacrolimus:** Omeprazole can increase tacrolimus blood levels, necessitating close monitoring and dose adjustments.
* **Digoxin:** Omeprazole can increase digoxin absorption, leading to elevated digoxin levels and potential toxicity.
* **Iron salts, ketoconazole, itraconazole, and erlotinib:** Omeprazole reduces gastric acidity, which can decrease the absorption of drugs that require an acidic environment for absorption.
* **St. John's Wort and Rifampin:** These substances can induce CYP2C19 and CYP3A4, potentially reducing omeprazole levels and efficacy.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Omeprazole is typically taken once daily, usually in the morning, at least 30 to 60 minutes before a meal. Taking it before food allows the drug to be absorbed and reach the parietal cells when they are most active in acid production, maximizing its effectiveness. For conditions requiring a twice-daily dose, the second dose is generally taken before the evening meal. For controlled/prescription compounds, dose is user-directed and must be set by a licensed clinician. Consistency in timing is important for optimal acid control (FDA label, MedlinePlus).
Source for this section: Sources for When should you take Omeprazole?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Omeprazole?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
| Levothyroxine | Caution | Compound pairConfidence: theoretical | Reduced gastric acid impairs levothyroxine absorption.Source pending | Monitor TSH after starting/stopping PPI; dose adjustment may be needed. |
Frequently asked questions about Omeprazole
Omeprazole is a medication. It is also known as prilosec. What follows is drawn from peer-reviewed literature indexed on PubMed, FDA label text where a label exists, and NIH reference records.
Omeprazole is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Omeprazole, it is typically taken in the morning and it is usually taken on an empty stomach. Always follow the specific dose your clinician or the product label prescribes.
Omeprazole carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Omeprazole is classified as a controlled substance in some jurisdictions, so legal status and prescribing rules apply. Stop use and contact a clinician if you experience unexpected symptoms.
Omeprazole is a medication, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Omeprazole is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Omeprazole with no sign-up.
Combining a medication like Omeprazole with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Omeprazole: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Omeprazole varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Most protocols have it taken on an empty stomach. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Omeprazole depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Omeprazole the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Omeprazole?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Clopidogrel with or without omeprazole in coronary artery disease(opens PubMed in a new tab)N Engl J Med · 2010 · PMID 20925534 · https://pubmed.ncbi.nlm.nih.gov/20925534/
- 2.Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis(opens PubMed in a new tab)Int J Clin Pharmacol Ther · 2015 · PMID 26329348 · https://pubmed.ncbi.nlm.nih.gov/26329348/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 4594(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/4594
Verify at
Publisher search links for Omeprazole. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Omeprazole?
Plain-text summary, safe to quote verbatim:
Omeprazole is a medication classified as a proton pump inhibitor (PPI). It is widely used to reduce the amount of acid produced in the stomach. It is typically taken in the morning. Omeprazole is a controlled substance in some jurisdictions.
Source: DoseRoutine — https://doseroutine.com/library/omeprazole
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Omeprazole — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/omeprazole
What compounds are similar to Omeprazole?
Others in the medication category or studied for the same goals.